Recent Progress In Aptamer Discoveries And Modifications For Therapeutic Applications
Shuaijian Ni,Zhenjian Zhuo,Yufei Pan,Yuanyuan Yu,Fangfei Li,Jin Liu,Luyao Wang,Xiaoqiu Wu,Dijie Li,Youyang Wan,Lihe Zhang,Zhenjun Yang,Bao-Ting Zhang,Aiping Lu,Ge Zhang
DOI: https://doi.org/10.1021/acsami.0c05750
IF: 9.5
2021-01-01
ACS Applied Materials & Interfaces
Abstract:Aptamers are oligonucleotide sequences with a length of about 25-80 bases which have abilities to bind to specific target molecules that rival those of monoclonal antibodies. They are attracting great attention in diverse clinical translations on account of their various advantages, including prolonged storage life, little batch-to-batch differences, very low immunogenicity, and feasibility of chemical modifications for enhancing stability, prolonging the half-life in serum, and targeted delivery. In this Review, we demonstrate the emerging aptamer discovery technologies in developing advanced techniques for producing aptamers with high performance consistently and efficiently as well as requiring less cost and resources but offering a great chance of success. Further, the diverse modifications of aptamers for therapeutic applications including therapeutic agents, aptamer-drug conjugates, and targeted delivery materials are comprehensively summarized.